CELLUTEX
CELLUTEX, licence 00721158: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- BIO-DIS Inc. (9185-5908 Quebec Inc.)
- NPN or DIN-HM
- 00721158
- Status
- Active licence
- Licence date
- 13 January 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Conditions légales
Filipendula ulmaria (L.) Maxim.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus laurocerasus Source : Tail | 50.0 mg | Not calculated |
| Filipendula ulmaria Source : Herbe en fleurs | 50.0 mg | Not calculated |
| Petroselinum crispum Source : Feuille(s) | 50.0 mg | Not calculated |
Non-medicinal ingredients
Glycyrrhiza glabra, Rosa canina, Cellulose, microcristalline, Octadécanoate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Antiseptique des voies urinaires. Aides à diminuer la rétention d'eau.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins si les symptômes persistent ou s`aggravent. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez. Consulter un praticien de soins de santé avant d'en faire l'usage si vous souffrez de trouble de foie ou de la vésicule biliaire, ou d'une obstruction intestinale.
Source
Official Health Canada record, licence 00721158
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.